Fundz

Adicet Bio, Inc. reported raising $11.3 Million in an initial SEC Form D filing, from an offering of $13.9 Million

PRIVATEJan 27, 2016$11.3M of $13.9M raised

Amount Raised

$11.3 Million

$11.3 Million sold, per SEC Form D (first sale Jan 27, 2016)

Round Type

Venture

Redwood CityBiotechnology

Quick answer

Adicet Bio, Inc. raised $11.3 Million in a funding round, dated January 27, 2016. Adicet Bio, Inc. is based in Redwood City, California, United States.

How much did Adicet Bio, Inc. raise?
Adicet Bio, Inc. raised $11.3 Million in a funding round on January 27, 2016.
What does Adicet Bio, Inc. do?
Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer.
Where is Adicet Bio, Inc. based and how big is it?
Adicet Bio, Inc. is based in Redwood City, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Adicet Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Velosal Medical, Inc. raised $20K (Pre-Seed) on March 11, 2016.
  • Infusesafe,LLC raised $2.3M (Seed) on March 9, 2016.
  • PRECIGEN, INC. raised $4.3M (Seed) on March 9, 2016.
  • GeneCapture raised $120K (Pre-Seed) on March 8, 2016.
  • CHIP Diagnostics, Inc. raised $250K on March 8, 2016.
  • Lung Therapeutics, Inc. raised $1M (Seed) on March 8, 2016.

Who to call at Adicet Bio, Inc., and when

A new round usually means Adicet Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Adicet Bio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Adicet Bio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Adicet Bio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Adicet Bio, Inc.

Location

1000 Bridge Parkway

Redwood City, California, United States

About

Adicet Bio, Inc. is a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. Adicet is advancing a pipeline of "off-the-shelf" gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Adicet Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Adicet Bio, Inc.'s next move

See what Strategic adds

Adicet Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.